PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement-Reference-Cited by-同舟云学术

PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement

Published:2013-07-04 Issue:1 Volume:122 Page:61-67
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Khan Anjum Bashir¹,Barrington Sally Fiona²,Mikhaeel Nabegh George³,Hunt Alesia Abigael¹,Cameron Laura¹,Morris Tim⁴,Carr Robert⁵

Affiliation:

1. Department of Haematology, Guy’s and St Thomas’ Foundation Trust, London, United Kingdom;

2. PET Imaging Centre at St Thomas’ Hospital, King’s College, London, United Kingdom;

3. Department of Clinical Oncology, Guy’s and St Thomas’ Foundation Trust, London, United Kingdom;

4. Clinical Trials Unit, Medical Research Council, London, United Kingdom; and

5. Department of Haematology, Guy’s and St Thomas’ Hospital, King’s College, London, United Kingdom

Abstract

Key Points Routine staging by PET-CT identifies all clinically relevant marrow involvement by DLBCL. Cases with marrow involvement identified by PET-CT have PFS and overall survival similar to stage IV cases without marrow involvement.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/1/61/1368934/61.pdf

Reference31 articles.

1. Bone marrow and blood involvement by non-Hodgkin’s lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation.;Morra;Eur J Haematol,1989

2. Bone marrow involvement by non-Hodgkin’s lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow.;Conlan;J Clin Oncol,1990

3. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.;Campbell;Eur J Haematol,2006

4. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.;Zinzani;Br J Cancer,2004

5. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?;Raanani;Ann Oncol,2006

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Tumor Burden is Associated with Bone Marrow Involvement in Low-grade;2024-05-02

2. B-cell non-Hodgkin lymphomas;The Lancet;2024-05

3. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [ ¹⁸ F]FDG-PET/CT and bone marrow biopsy findings;Current Medical Research and Opinion;2024-04-16

4. 18F-FDG PET/CT versus bone marrow biopsy in detecting bone marrow infiltration in initial staging of pediatric lymphoma;EJNMMI Reports;2024-04-15

5. A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL;Frontiers in Oncology;2024-03-21